End stage renal disease

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1 Phase II: 1 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Iperboreal Pharma S.r.l. Commercial
    LEVOCARNITINE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, GLUCOSE MONOHYDRATE, SODIUM LACTATE
    2024-512078-88-00 1 country 2024 n=20
    Halted

Phase II

1 trial
  • Medical University Of Vienna Academic
    OM336
    2025-523222-40-00 1 country n=6
    Not authorised

Phase IV

1 trial
  • Consorci Mar Parc De Salut De Barcelona Academic
    IMP not specified
    2025-520535-16-00 1 country 2025 n=270
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Iperboreal Pharma S.r.l. Commercial 1 Phase III 0
Medical University Of Vienna Academic 1 Phase II 0
Consorci Mar Parc De Salut De Barcelona Academic 1 Phase IV 1
New trials by year
2024
1
2025
1
← All indication landscapes